Cinnamic acid and lactobionic acid based nanoformulations as a potential antiamoebic therapeutics.
暂无分享,去创建一个
R. Siddiqui | N. Khan | N. Akbar | Muhammad Kawish | Tooba Jabri | M. Shah
[1] R. Siddiqui,et al. Nanovesicles containing curcumin hold promise in the development of new formulations of anti-Acanthamoebic agents. , 2021, Molecular and biochemical parasitology.
[2] L. Weaver,et al. High oxygen concentrations inhibit Acanthamoeba spp. , 2021, Parasitology Research.
[3] M. Khamis,et al. Cationic Surfactant–Natural Clay Complex as a Novel Agent Against Acanthamoeba castellanii Belonging to the T4 Genotype , 2021, Eye & contact lens.
[4] J. McKerrow,et al. Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs , 2021, Expert review of anti-infective therapy.
[5] J. Lorenzo-Morales,et al. In vitro amoebicidal effects of arabinogalactan-based ophthalmic solution , 2021, International journal for parasitology. Drugs and drug resistance.
[6] R. Siddiqui,et al. Development of anti-acanthamoebic approaches , 2021, International Microbiology.
[7] J. Lorenzo-Morales,et al. In vitro validation of the amoebicidal activity of commercial eye drops as second activity , 2021, International journal for parasitology. Drugs and drug resistance.
[8] A. Elhissi,et al. Galactosylated iron oxide nanoparticles for enhancing oral bioavailability of ceftriaxone , 2021, Pharmaceutical development and technology.
[9] N. Durán,et al. New Sustainable Process for Hesperidin Isolation and Anti-Ageing Effects of Hesperidin Nanocrystals , 2020, Molecules.
[10] Ayaz Anwar,et al. Metronidazole conjugated magnetic nanoparticles loaded with amphotericin B exhibited potent effects against pathogenic Acanthamoeba castellanii belonging to the T4 genotype , 2020, AMB Express.
[11] B. Malaekeh-Nikouei,et al. The role of nanotechnology in combating biofilm-based antibiotic resistance , 2020 .
[12] S. Bonini,et al. Acanthamoeba Keratitis: Perspectives for Patients , 2020, Current eye research.
[13] B. Ankamwar,et al. A Review on Antimicrobial Properties of Metal Nanoparticles. , 2020, Journal of nanoscience and nanotechnology.
[14] A. Elhissi,et al. Enhancement in Oral Absorption of Ceftriaxone by Highly Functionalized Magnetic Iron Oxide Nanoparticles , 2020, Pharmaceutics.
[15] R. Siddiqui,et al. Antibacterial Activities of Selected Pure Compounds Isolated from Gut Bacteria of Animals Living in Polluted Environments , 2020, Antibiotics.
[16] J. McKerrow,et al. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii , 2020, Antimicrobial Agents and Chemotherapy.
[17] G. Sethi,et al. Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements , 2020, Experimental biology and medicine.
[18] M. R. Shah,et al. Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492) , 2020, AMB Express.
[19] G. Amaratunga,et al. Graphene oxide based nano-composite for sustained release of cephalexin. , 2020, Journal of pharmaceutical sciences.
[20] W. Sullivan,et al. Repositioning of guanabenz in conjugation with gold and silver nanoparticles against pathogenic amoebae Acanthamoeba castellanii and Naegleria fowleri. , 2019, ACS infectious diseases.
[21] R. Siddiqui,et al. Gut Bacteria of Water Monitor Lizard (Varanus salvator) Are a Potential Source of Antibacterial Compound(s) , 2019, Antibiotics.
[22] A. Tsatsakis,et al. Cardioprotective effects of hesperidin on carbon monoxide poisoned in rats , 2019, Drug and chemical toxicology.
[23] Mohammad Khalid,et al. Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii , 2019, Parasites & Vectors.
[24] Z. Kong,et al. Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells , 2019, International journal of molecular sciences.
[25] A. Mahmoud,et al. Beneficial Effects of Citrus Flavonoids on Cardiovascular and Metabolic Health , 2019, Oxidative medicine and cellular longevity.
[26] J. van Griensven,et al. Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens. , 2019, Infectious disease clinics of North America.
[27] K. Rajendran,et al. Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids , 2019, Scientific Reports.
[28] Naveen Samuel Singh,et al. A Review on Major Risk Factors and Current Status of Visceral Leishmaniasis in North India , 2019, American Journal of Entomology.
[29] M. Morales,et al. Aggregation effects on the magnetic properties of iron oxide colloids , 2019, Nanotechnology.
[30] B. Seitz,et al. Acanthamoeba keratitis – Clinical signs, differential diagnosis and treatment , 2018, Journal of current ophthalmology.
[31] D. K. Majumdar,et al. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery , 2018, Pharmaceutical development and technology.
[32] S. Paul,et al. Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species , 2018, Ayu.
[33] E. Morii,et al. A case report of granulomatous amoebic encephalitis by Group 1 Acanthamoeba genotype T18 diagnosed by the combination of morphological examination and genetic analysis , 2018, Diagnostic Pathology.
[34] M. R. Shah,et al. Gum acacia stabilized silver nanoparticles based nano-cargo for enhanced anti-arthritic potentials of hesperidin in adjuvant induced arthritic rats , 2018, Artificial cells, nanomedicine, and biotechnology.
[35] Ayaz Anwar,et al. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole , 2017, Parasitology Research.
[36] Zhengyu Jin,et al. Linear dextrin as curcumin delivery system: Effect of degree of polymerization on the functional stability of curcumin , 2017 .
[37] Meijia Wu,et al. Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment. , 2017, Molecular and clinical oncology.
[38] R. Bucki,et al. Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity , 2017, International journal of nanomedicine.
[39] Ayaz Anwar,et al. Future Priorities in Tackling Infections Due to Brain-Eating Amoebae. , 2017, ACS chemical neuroscience.
[40] A. El-Karef,et al. Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways , 2017, Life sciences.
[41] M. Natan,et al. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance. , 2017, FEMS microbiology reviews.
[42] A. López-Arencibia,et al. Amoebicidal Activity of Caffeine and Maslinic Acid by the Induction of Programmed Cell Death in Acanthamoeba , 2017, Antimicrobial Agents and Chemotherapy.
[43] Naveed Ahmed Khan,et al. Pathogenesis of microbial keratitis. , 2017, Microbial pathogenesis.
[44] L. Shao,et al. The antimicrobial activity of nanoparticles: present situation and prospects for the future , 2017, International journal of nanomedicine.
[45] H. Tenhu,et al. Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering , 2017, Nanoscale Research Letters.
[46] Gareth R Williams,et al. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. , 2016, Carbohydrate polymers.
[47] L. Gonçalves,et al. NANOBIOCATALYTIC SYSTEMS BASED ON LIPASE-Fe3O4 AND CONVENTIONAL SYSTEMS FOR ISONIAZID SYNTHESIS: A COMPARATIVE STUDY , 2016 .
[48] Marisa Papaluca,et al. Nanomedicines in the EU—Regulatory Overview , 2016, The AAPS Journal.
[49] A. Elhissi,et al. Glycoside-based niosomal nanocarrier for enhanced in-vivo performance of Cefixime. , 2016, International journal of pharmaceutics.
[50] V. Rotello,et al. Nanoparticle-Based Antimicrobials: Surface Functionality is Critical , 2016, F1000Research.
[51] F. Stapleton,et al. Strategies for the prevention of contact lens‐related Acanthamoeba keratitis: a review , 2016, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[52] S. Das,et al. Antibacterial Effects of Biosynthesized Silver Nanoparticles on Surface Ultrastructure and Nanomechanical Properties of Gram-Negative Bacteria viz. Escherichia coli and Pseudomonas aeruginosa. , 2016, ACS applied materials & interfaces.
[53] Damien Mertz,et al. Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. , 2016, Nanoscale.
[54] Bibekanand Mallick,et al. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface , 2015, Scientific Reports.
[55] P. Mutlu,et al. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[56] Surinder P. Singh,et al. The role of nanotechnology in combating multi-drug resistant bacteria. , 2014, Journal of nanoscience and nanotechnology.
[57] P. Scheid,et al. First report of an Acanthamoeba genotype T13 isolate as etiological agent of a keratitis in humans , 2014, Parasitology Research.
[58] M. T. Wong,et al. Mechanisms of antibacterial activity of MgO: non-ROS mediated toxicity of MgO nanoparticles towards Escherichia coli. , 2014, Small.
[59] Rong-Kun Chang,et al. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems. , 2013, Journal of pharmaceutical sciences.
[60] M. Sharifdini,et al. Pathogenic Assays of Acanthamoeba Belonging to the T4 Genotype , 2013, Iranian journal of parasitology.
[61] A. López-Arencibia,et al. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? , 2013, Trends in parasitology.
[62] Dik van de Meent,et al. Considerations on the EU definition of a nanomaterial: science to support policy making. , 2013, Regulatory toxicology and pharmacology : RTP.
[63] Vladimir P. Torchilin,et al. Challenges in Development of Targeted Liposomal Therapeutics , 2012, The AAPS Journal.
[64] Naveed Ahmed Khan,et al. Biology and pathogenesis of Acanthamoeba , 2012, Parasites & Vectors.
[65] Vivek Dhawan,et al. Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration. , 2011, Molecular pharmaceutics.
[66] Rupesh Kumar Basniwal,et al. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. , 2011, Journal of agricultural and food chemistry.
[67] Jyh-Ping Chen,et al. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator , 2011 .
[68] Basilio Valladares,et al. The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. , 2008, Journal of medical microbiology.
[69] N. Khan,et al. The role of proteases in the differentiation of Acanthamoeba castellanii. , 2008, FEMS microbiology letters.
[70] Yong-mei Li,et al. In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts. , 2008, Journal of agricultural and food chemistry.
[71] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[72] K. Kim,et al. Balamuthia mandrillaris interactions with human brain microvascular endothelial cells in vitro. , 2007, Journal of medical microbiology.
[73] Yongmin Chang,et al. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. , 2007, Biomaterials.
[74] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[75] J. Pérez-Santonja,et al. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. , 2003, Ophthalmology.
[76] J. Bessière,et al. The essential oils of Rinorea subintegrifolia O. Ktze and Drypetes gossweileri S. Moore occurring in Gabon , 2003 .
[77] S. Sarker,et al. Pyranoisoflavones from Rinorea welwitschii. , 2000, Fitoterapia.
[78] A. Ghidan,et al. Exploration of Antioxidant, Antibacterial Activities of Green Synthesized Hesperidin Loaded PLGA Nanoparticles , 2021, Biointerface Research in Applied Chemistry.
[79] S. Srinivasan,et al. Antidiabetic Efficacy of Citrus Fruits With Special Allusion to Flavone Glycosides , 2019, Bioactive Food as Dietary Interventions for Diabetes.
[80] H. K. Manjili,et al. Anticancer Activity of Tamoxifen Loaded Tyrosine Decorated Biocompatible Fe3O4 Magnetic Nanoparticles Against Breast Cancer Cell Lines , 2017, Journal of Inorganic and Organometallic Polymers and Materials.
[81] S. Lata,et al. ROLE OF NANOTECHNOLOGY IN DRUG DELIVERY , 2017 .
[82] Mukta Bhatele,et al. A Brief Review on Role of Nanotechnology in Medical Sciences , 2013 .
[83] P. Cullis,et al. Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.
[84] C. Bunce,et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. , 2008, American journal of ophthalmology.
[85] Myung‐Sook Choi,et al. Interactive effect of hesperidin and vitamin E supplements on cholesterol metabolism in high cholesterol-fed rats. , 2001, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[86] Y. Barenholz,et al. Annals of the New York Academy of Sciences Nanomedicines: Addressing the Scientific and Regulatory Gap , 2022 .